Richard Cramer
Richard Cramer
Bilinmeyen bağlantı
tripos.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins
RD Cramer, DE Patterson, JD Bunce
Journal of the American Chemical Society 110 (18), 5959-5967, 1988
32211988
Validation of the general purpose Tripos 5.2 force field
M Clark, RD Cramer III, N Van Opdenbosch
Journal of Computational Chemistry 10 (8), 982-1012, 1989
29451989
Patterson, DE and Bunce, JD
RD Cramer
J. Amer. Chem. Soc 11, 5959, 1988
16481988
QSAR modeling: where have you been? Where are you going to?
A Cherkasov, EN Muratov, D Fourches, A Varnek, II Baskin, M Cronin, ...
Journal of medicinal chemistry 57 (12), 4977-5010, 2014
11052014
Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies
RD Cramer III, JD Bunce, DE Patterson, IE Frank
Quantitative Structure‐Activity Relationships 7 (1), 18-25, 1988
10771988
Neighborhood behavior: a useful concept for validation of “molecular diversity” descriptors
DE Patterson, RD Cramer, AM Ferguson, RD Clark, LE Weinberger
Journal of medicinal chemistry 39 (16), 3049-3059, 1996
5691996
The probability of chance correlation using partial least squares (PLS)
M Clark, RD Cramer III
Quantitative Structure‐Activity Relationships 12 (2), 137-145, 1993
3481993
DL-MU-CHLOROTETRAKIS (ETHYLENE) DIRHODIUM (I), 2, 4-PENTANEDIONATOBIS (ETHYLENE) RHODIUM (I), AND DL-MU-CHLOROTETRACARBONYLDIRHODIUM (I)
R Cramer
2601974
Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases
M Clark, RD Cramer III, DM Jones, DE Patterson, PE Simeroth
Tetrahedron Computer Methodology 3 (1), 47-59, 1990
2321990
Partial least squares (PLS): its strengths and limitations
RD Cramer
Perspectives in Drug Discovery and Design 1 (2), 269-278, 1993
2081993
Substructural analysis. Novel approach to the problem of drug design
RD Cramer III, G Redl, CE Berkoff
Journal of Medicinal Chemistry 17 (5), 533-535, 1974
2081974
Topomer CoMFA: a design methodology for rapid lead optimization
RD Cramer
Journal of medicinal chemistry 46 (3), 374-388, 2003
2032003
Tin (II) chloride complexes of platinum metals
RD Cramer, FL Jenner, RV Lindsey, VG Stolberg
J. Am. Chem. Soc 85, 1691, 1963
1851963
BC (DEF) parameters. 1. The intrinsic dimensionality of intermolecular interactions in the liquid state
RD Cramer III
Journal of the American Chemical Society 102 (6), 1837-1849, 1980
1721980
The developing practice of comparative molecular field analysis
P Hecht
3D QSAR in drug design 1, 443, 1993
1641993
Bioisosterism as a molecular diversity descriptor: steric fields of single “topomeric” conformers
RD Cramer, RD Clark, DE Patterson, AM Ferguson
Journal of medicinal chemistry 39 (16), 3060-3069, 1996
1571996
Ⅲ, Patterson DE, Bunce JD
RD Cramer
Comparative Molecular Field Analysis (CoMFA) 1, 5959-5967, 1988
1561988
Three-dimensional structure-activity relationships
GR Marshall, RD Cramer III
Trends in pharmacological sciences 9 (8), 285-289, 1988
1541988
Molecular orbital theory calculations of aqueous solvation effects on chemical equilibria
CJ Cramer, DG Truhlar
Journal of the American Chemical Society 113 (22), 8552-8554, 1991
138*1991
Comparative molecular field analysis (CoMFA)
RD Cramer III, SB Wold
US Patent 5,025,388, 1991
1291991
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20